Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: Dementia

MIT study reveals how specific cells in AD become vulnerable and resilient

MIT study reveals how specific cells in AD become vulnerable and resilient
p p Read More

The neurodegenerative condition is recognised as the most common form of dementia

July 29, 2024 Alzheimer's disease, Dementia, Massachusetts Institute of Technology, neurodegenerative diseases, News, reelin, Religious Order Study, Rush Memory and Aging Project

Innovate UK grants £4m to four companies to evaluate biomarkers for dementia

Innovate UK grants £4m to four companies to evaluate biomarkers for dementia
p p Read More

The progressive neurodegenerative disease affects more than 55 million people globally

July 12, 2024 Bio-Hermes-002, Contracts for Innovation, Dementia, Global Alzheimer's Platform Foundation, innovate UK, News, Novo Nordisk

UK DRI and NHS collaborate on digitally enabled dementia care platform

UK DRI and NHS collaborate on digitally enabled dementia care platform
p p Read More

Around one in five dementia hospitalisations are due to potentially preventable causes

July 10, 2024 artificial intelligence, Dementia, LifeArc, Minder, News, NHS, UK Dementia Research Institute

Institutions to lead £1.7m-funded network to support people at risk of dementia

Institutions to lead £1.7m-funded network to support people at risk of dementia
p p Read More

The neurodegenerative condition currently affects more than 944,000 people in the UK

July 10, 2024 Dementia, Innovation and Involvement NETwork, News, Sustainable Prevention, University College London, University of Exeter

Study reveals cardiovascular health could be biggest risk factor for dementia

Study reveals cardiovascular health could be biggest risk factor for dementia
p p Read More

Dementias, including Alzheimer’s disease, are estimated to affect 944,000 people in the UK

July 3, 2024 Dementia, National Institute for Health and Care Research, News, NICE Three School's Dementia Research Programme, University College London

Researchers reveal how a protein interaction can increase Alzheimer’s risk

Researchers reveal how a protein interaction can increase Alzheimer’s risk
p p Read More

AD is the most common form of dementia, which affects over 944,000 people in the UK

June 26, 2024 Alzheimer's disease, amyloid-beta, APOE4, Dementia, neurodgenerative diseases, News, Sheffield Institute of Translational Neuroscience, UK Dementia Research Institute, university of sheffield

UK dementia organisations publish new manifesto ahead of general election

UK dementia organisations publish new manifesto ahead of general election
p p Read More

The manifesto calls on the next UK government to make dementia a key health priority

June 24, 2024 Alzheimer Scotland, Alzheimer's Research UK, Alzheimer’s Society, Dementia, Dementia UK, Dementia: a manifesto, neurodegenerative diseases, News, UK Dementia Research Institute

Study links dementia antipsychotics to higher risks of serious health outcomes

The neurodegenerative condition currently affects more than 944,000 people living in the UK

April 22, 2024 antipsychotics, Dementia, News, University of Dundee, University of Edinburgh, University of Manchester, University of Nottingham

Researchers suggest form of Alzheimer’s is transmissible via bone marrow transplants

The progressive neurodegenerative disease is estimated to affect 24 million people globally

April 3, 2024 Alzheimer's disease, amyloid, amyloid precursor protein, bone marrow transplants, Dementia, neurodegenerative diseases, News, University of British Columbia

Innovate UK awards ten projects over £6m to develop new clinical tools for dementia

Dementia is estimated to affect 850,000 people in the UK and costs the nation around £23bn a year

March 22, 2024 clinical tools, Dementia, innovate UK, neurodegeneration, News, Small Business Research Institute, UK life sciences

Posts navigation

« Previous

Posts pagination

1 2 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy